Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

859
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
859
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
Angina IV: Management01:26

Angina IV: Management

495
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
495

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of small dense LDL cholesterol and inflammation with plaque rupture in acute coronary syndrome: An OCT study.

Journal of clinical lipidology·2026
Same author

Impact of Geographic Factors on Outpatient Cardiac Rehabilitation Adherence After Transcatheter Aortic Valve Implantation.

Circulation reports·2026
Same author

Short-Term Effects of Ambient Temperature on Acute Heart Failure Decompensation: Phenotype-Specific Risk in a Time-Stratified Case-Crossover Study.

Circulation. Heart failure·2026
Same author

Small Dense Low-Density Lipoprotein Cholesterol Predicts Long-Term Coronary Artery Disease Recurrence in Patients Without Metabolic Dyslipidemia.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

CORRIGENDUM: JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.

Circulation journal : official journal of the Japanese Circulation Society·2025
Same author

The Japan Geriatrics Society 2025 Position Statement on End-of-Life Care for Older Adults: English Translation of the Japanese Article.

Geriatrics & gerontology international·2025

Related Experiment Video

Updated: May 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

[Statin therapy for atherogenic hypertriglyceridemia].

Shinji Koba1

  • 1Division of Cardiology, Department of Medicine, Showa University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 12, 2013
PubMed
Summary
This summary is machine-generated.

Statins effectively lower LDL-cholesterol, reducing heart disease and stroke risk. Stronger statins like rosuvastatin offer greater reductions in triglycerides and small dense LDL particles.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K

Related Experiment Videos

Last Updated: May 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.2K

Area of Science:

  • Cardiovascular Pharmacology
  • Lipid Metabolism
  • Pharmacotherapy

Context:

  • Statins are primary agents for lowering low-density lipoprotein (LDL) cholesterol.
  • Elevated LDL and triglycerides are key risk factors for coronary heart disease (CHD) and ischemic stroke.
  • Accumulation of remnant lipoproteins contributes to atherogenic small dense LDL formation.

Purpose:

  • To highlight the efficacy of statins in managing dyslipidemia.
  • To differentiate the lipid-lowering effects of various statin potencies.
  • To emphasize the role of statins in reducing cardiovascular morbidity and mortality.

Summary:

  • Statins significantly reduce morbidity and mortality associated with CHD and ischemic stroke by lowering LDL-cholesterol.
  • Strong statins (rosuvastatin, atorvastatin, pitavastatin) demonstrate superior efficacy in reducing triglycerides and small dense LDL compared to other statins.
  • Statins are first-line treatments for hypertriglyceridemia with elevated LDL- and/or non-HDL cholesterol, with aggressive lowering needed for high-risk CHD patients.

Impact:

  • Provides evidence for selecting potent statins in high-risk cardiovascular patients.
  • Informs clinical practice regarding lipid management strategies.
  • Contributes to understanding the mechanisms of statin action on atherogenic lipoproteins.